Mersana Therapeutics, Inc. has been removed from NASDAQ Biotechnology Index .
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.065 USD | +4.25% | -4.60% | +29.53% |
Mar. 20 | North American Morning Briefing : Markets on Hold -2- | DJ |
Mar. 19 | JPMorgan Upgrades Mersana Therapeutics to Neutral From Underweight, Price Target is $5 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+29.53% | 360M | |
-2.57% | 103B | |
+1.74% | 95.28B | |
+1.46% | 22.15B | |
-15.31% | 21.02B | |
-8.58% | 18.15B | |
-41.01% | 16.73B | |
-13.43% | 16.05B | |
+4.29% | 13.68B | |
+35.53% | 12.17B |
- Stock Market
- Equities
- MRSN Stock
- News Mersana Therapeutics, Inc.
- Mersana Therapeutics, Inc.(NasdaqGS: MRSN) dropped from NASDAQ Biotechnology Index